http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002169129-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate | 2002-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85bced5debb199db0242f485ee1f348a |
| publicationDate | 2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002169129-A1 |
| titleOfInvention | Method for improving the quality of life of patients by administration of erythropoietin (RhuEPO) |
| abstract | A method for providing various benefits with the administration of different quantities of Erythropoietin. The method provides for enhancing the of quality of life by administration of Erythropoietin before a substantial increases in hemoglobin occurs. The improvement in quality of life is independent of the hemopoietic effect. In larger quantities the administration of RhuEPO leads to repair of vascular damage and leads to the redistribution of the iron trapped in storage organs, from where it cannot be used for red blood cell production, into the hemopoietic system leading to enhanced red blood cell production. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004132645-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009220595-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007054600-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8343917-B2 |
| priorityDate | 1998-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 119.